Author's response Comments on: Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v (PresVu eye drops) versus placebo ophthalmic solution for the treatment of presbyopia – A multicentric clinical trial

Parul Singh, Tejal Garasiya, Vidya Ajila, Sabyasachi Sengupta, Aditi Datta, Nivean Madhivanan

Open source

DOI: 10.4103/ijo.ijo_2955_25
Published: 4
Container: Indian Journal of Ophthalmology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4103/ijo.ijo_2955_25,
  title = {Author's response Comments on: Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25\% w/v (PresVu eye drops) versus placebo ophthalmic solution for the treatment of presbyopia – A multicentric clinical trial},
  author = {Parul Singh and Tejal Garasiya and Vidya Ajila and Sabyasachi Sengupta and Aditi Datta and Nivean Madhivanan},
  year = {2026},
  journal = {Indian Journal of Ophthalmology},
  doi = {10.4103/ijo.ijo_2955_25},
  url = {https://doi.org/10.4103/ijo.ijo_2955_25}
}

RIS

TY  - JOUR
TI  - Author's response Comments on: Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v (PresVu eye drops) versus placebo ophthalmic solution for the treatment of presbyopia – A multicentric clinical trial
AU  - Parul Singh
AU  - Tejal Garasiya
AU  - Vidya Ajila
AU  - Sabyasachi Sengupta
AU  - Aditi Datta
AU  - Nivean Madhivanan
PY  - 2026
JO  - Indian Journal of Ophthalmology
DO  - 10.4103/ijo.ijo_2955_25
UR  - https://doi.org/10.4103/ijo.ijo_2955_25
ER  -

APA

Singh, P., Garasiya, T., Ajila, V., Sengupta, S., Datta, A., & Madhivanan, N. (2026). Author's response Comments on: Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v (PresVu eye drops) versus placebo ophthalmic solution for the treatment of presbyopia – A multicentric clinical trial. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_2955_25

Source records

doaj · retrieved 2026-09-26T08:44:38.854Z